LEADER 03274nam 2200637 a 450 001 9910782696503321 005 20230607222332.0 010 $a1-74219-431-1 010 $a1-74219-102-9 010 $a1-74219-100-2 035 $a(CKB)1000000000693130 035 $a(EBL)410437 035 $a(OCoLC)476232844 035 $a(SSID)ssj0000186948 035 $a(PQKBManifestationID)11166780 035 $a(PQKBTitleCode)TC0000186948 035 $a(PQKBWorkID)10252948 035 $a(PQKB)11668927 035 $a(MiAaPQ)EBC410437 035 $a(Au-PeEL)EBL410437 035 $a(CaPaEBR)ebr10273696 035 $a(EXLCZ)991000000000693130 100 $a20010824d2001 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aKath Williams$b[electronic resource] $ethe unions and the fight for equal pay /$fZelda D'Aprano 210 $aNorth Melbourne $cSpinifex Press$d2001 215 $a1 online resource (322 p.) 300 $aDescription based upon print version of record. 311 $a1-306-09967-6 311 $a1-876756-02-0 320 $aIncludes bibliographical references (p. [278]-285) and index. 327 $aBook Cover; Title; Copyright; Contents; Acknowledgements; Foreword; Abbreviations; Preface; Editorial note; 1 Cath the housewife/mother becomes Kath the activist; 2 An early history of women and unionism; 3 Women's postwar moves on equal pay and the ACTU; 4 Decisions on equal pay, 1891 to 1955; 5 The fight for equal pay, 1956 to 1959; 6 1960 to 1962, the fight escalates; 7 Kath resigns from the Communist Party of Australia; 8 1963 to 1964, the ACTU and equal pay; 9 1965 to 1967: the ACTU gears up for action as Kath begins to retire 327 $a10 The ACTU changes policy: from urging legislation to preparing a claim for equal pay11 The equal pay case of 1969; 12 Equal pay for work of equal value; 13 Kath and male structures; 14 Women, work and the fight for pay justice; Appendix 1 Noteworthy decisions on pay; Appendix 2 The Victorian Working Women's Centre; Interviews; Notes; Bibliography; Index 330 $aOne of Australia's most important activists for women's rights, Kath Williams was a trade unionist and a communist before taking on the mantle of feminist after World War II. With a trade unionist ex-husband who was elected to Federal Politics opposing her left wing campaigns, Kath emerged as a feisty and quietly determined woman. Her campaign of conviction was the major force behind the country's achievement of equal pay for women. 606 $aWomen labor union members$zAustralia$vBiography 606 $aWomen labor union members$zAustralia$xHistory 606 $aEqual pay for equal work$zAustralia$xHistory 606 $aLabor unions$zAustralia$xHistory 615 0$aWomen labor union members 615 0$aWomen labor union members$xHistory. 615 0$aEqual pay for equal work$xHistory. 615 0$aLabor unions$xHistory. 676 $a305.4092 676 $a331.478092 700 $aD'Aprano$b Zelda$f1928-$01539480 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910782696503321 996 $aKath Williams$93790422 997 $aUNINA LEADER 05465nam 22005775 450 001 9910633917403321 005 20251009100751.0 010 $a3-031-08774-7 024 7 $a10.1007/978-3-031-08774-5 035 $a(MiAaPQ)EBC7150350 035 $a(Au-PeEL)EBL7150350 035 $a(CKB)25504307000041 035 $a(PPN)266354521 035 $a(DE-He213)978-3-031-08774-5 035 $a(OCoLC)1352969516 035 $a(EXLCZ)9925504307000041 100 $a20221129d2022 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNeuroimaging Pharmacopoeia /$fedited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer 205 $a2nd ed. 2022. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2022. 215 $a1 online resource (413 pages) 225 1 $aMedicine Series 311 08$aPrint version: Ginat, Daniel Thomas Neuroimaging Pharmacopoeia Cham : Springer International Publishing AG,c2023 9783031087738 327 $aPART I: Drugs and Alcohol -- 1. Tobacco -- 2. Alcohol -- 3. Methanol -- 4. Cannabis (Marijuana) -- 5. Synthetic Cannabinoids (spice/K2 preparations) -- 6. Crack and Cocaine -- 7. Amphetamines -- 8. Opioids -- 9. Betel Nuts -- 10. Licorice -- 11. Centella asiatica -- PART II: Contrast Agents -- 12. Iodinated Contrast Agents -- 13. Gadolinium-Based Contrast Agents -- 14. Ferumoxytol -- 15. Pantopaque (Myodil, Iodophenylundecylic Acid) -- 16. Thorium Dioxide (Thorotrast) -- PART III: Chemotherapy -- 17. Temozolamide (Temodar) -- 18. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel) -- 19. Methotrexate -- 20. 5-Fluorouracil -- 21. L-Asparaginase (Elspar/Erwinase) -- 22. Calcineurin Inhibitors -- 23. Bromocriptine (Parlodel) and Cabergoline (Dostinex) -- 24. HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) -- PART IV: Anti-cancer Immunotherapy -- 25. Ipilimumab (MDX-010, Yervoy) -- 26. Bevacizumab (Avastin) -- 27. Chimeric Antigen Receptor T-Cell Therapy (tisagenlecleucel and axicabtagene ciloleucel) -- PART V: Antiobiotics, Antiviral Agents, and Vaccines -- 28. Metronidazole (Flagyl) -- 29. Iodoform -- 30. Isoniazid -- 31. Highly Active Antiretroviral Therapy (HAART) -- 32. Vaccines -- PART VI: Antiepilectic, Antipsychotic, and General Anesthgetic Agents -- 33. Dilantin (Phenytoin Sodium) -- 34. Valproic Acid (Sodium Valproate, Depakote) -- 35. Vigabatrin (Sabril) -- 36. Lithium -- 37. Neuroleptics -- PART VII: Anesthetic and Sedative Agents -- 38. Barbiturates (Pentobarbital) -- 39. Nitrous Oxide (N2O) -- 40. Propofol -- PART VIII: Hemostatic and Vasoactive Agents -- 41. Embolic Agents -- 42. Aspirin and Plavix/Clopidogrel -- 43. Warfarin (Coumadin) -- 44. Heparin -- 45. Tissue Plasminogen Activator (tPA) -- 46. Oxidized Cellulose -- 47. Nasal Decongestants -- PART IX: Cardiovascular Support Agents -- 48. Supplemental Oxygen -- 49. Hypertonic Saline -- 50. Mannitol (1,2,3,4,5,6-Hexanehexol) -- 51. Triple H Therapy -- 52. Angiotensin Converting Enzyme (ACE) Inhibitors -- 53. Acetazolamide (Diamox) -- 54. Amiodarone -- PART X: Anti-inflammatory Agents -- 55. Acetominophen (Tylenol, Paracetamol) -- 56. Natalizumab (Tysabri, Biogen IDEC and Elan Pharmaceuticals) -- 57. Synthetic Corticosteroids -- PART XI: Dietary Supplements, Homeostatic Agents, Hormone-like Drugs -- 58. Manganese in Total Parenteral Nutrition -- 59. Zinc Oxide (ZnO) -- 60. Insulin -- 61. Bisphosphonates -- 62. Recombinant Human Bone Morphogenetic Protein -- 63. Retinoids (13-cis-Retinoic Acid, Isotretinoin, Accutane, All-trans-retinoic acid) -- 64. Topical Prostaglandin Analogues -- 65. Oral Contraceptives (Estrogen and Progestin) -- 66. Fish Oil -- PART XII: Injectable Filler Agents -- 67. Calcium hydroxyapatite-based Fillers -- 68. Hyaluronic Acid-based Fillers -- 69. Injectable Silicone Oil. 330 $aThis book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The book?s closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike. . 410 0$aMedicine Series 606 $aRadiology 606 $aPharmacology 606 $aRadiology 606 $aPharmacology 615 0$aRadiology. 615 0$aPharmacology. 615 14$aRadiology. 615 24$aPharmacology. 676 $a616.804754 676 $a616.80475 702 $aGinat$b Daniel Thomas 702 $aSmall$b Juan E. 702 $aSchaefer$b Pamela W. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910633917403321 996 $aNeuroimaging Pharmacopoeia$92994417 997 $aUNINA